BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Cardiac Science Corporation

Cardiac Science Corporation is a global leader in the development, manufacture and marketing of diagnostic and therapeutic cardiology products and services. Formed by the merger of Cardiac Science, Inc. and Quinton Cardiology Systems in September 2005, the predecessor companies have a rich legacy of technology development in the market for cardiology devices. Cardiac Science Corporation provides a full spectrum of cardiology products and services that help protect hearts and save lives. From devices designed to identify the early stages of heart disease-such as Electrocardiographs, Cardiac Stress Testing Systems, and Holter Monitors-to sophisticated systems that enable Cardiac Rehabilitation and Cardiology Data Management-to innovative and patented automated external defibrillators (AEDs) that provide assistance to victims of sudden cardiac arrest for both medical and non-medical markets.


Contact Details:
3303 Monte Villa Parkway
Bothell
Washington
98021
United States of America
Tel:(425) 402-2000
Fax:
Email:investor@cardiacscience.com
WWW:

www.quinton.com/




Loading...

Recent Publications by Cardiac Science Corporation:

Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway.
The co-transmitter neuropeptide Y (NPY), released during prolonged cardiac...
5th August, 2008
Burdon Sanderson Cardiac Science Centre, Department of Physiology, Anatomy J Mol Cell Cardiol. 2008 Mar;44(3):477-85. Epub 2007 Oct 11.
DOI Direct Link
Measuring and modeling chloride-hydroxyl exchange in the Guinea-pig ventricular myocyte.
Protons are powerful modulators of cardiac function. Their intracellular...
23rd May, 2008
Burdon Sanderson Cardiac Science Centre, Department of Physiology, Anatomy Biophys J. 2008 Mar 15;94(6):2385-403. Epub 2007 Nov 30.
DOI Direct Link
Tumor-associated carbonic anhydrase 9 spatially coordinates intracellular pH in three-dimensional multicellular growths.
CA9 is a membrane-tethered, carbonic anhydrase (CA) enzyme, expressed...
17th May, 2008
Department of Physiology, Anatomy, and Genetics, Burdon Sanderson Cardiac J Biol Chem. 2008 Jul 18;283(29):20473-83. Epub 2008 May 15.
DOI Direct Link
S0859, an N-cyanosulphonamide inhibitor of sodium-bicarbonate cotransport in the heart.
BACKGROUND AND PURPOSE: Intracellular pH (pH(i)) in heart is regulated by...
16th May, 2008
Burdon Sanderson Cardiac Science Centre, Department of Physiology, Anatomy Br J Pharmacol. 2008 Mar;153(5):972-82. Epub 2008 Jan 21.
DOI Direct Link
Prediction of cardiovascular death using a novel heart rate recovery parameter.
INTRODUCTION: Reassertion of vagal tone after exercise is an important...
8th May, 2008
Cardiac Med Sci Sports Exerc. 2008 Jun;40(6):1072-9.
DOI Direct Link

View more Cardiac Science Corporation research publications.

BioNews Results for Cardiac Science Corporation:

Enrollment Complete in 15-Year Long-Term Follow-Up Study Evaluating Impact of AVONEX(R) in Patients with Relap
Calibre Macro World:  Aug 27 2008 8:32PM Matching: cardiac science
Corgenix, BG Medicine to Collaborate in Cardiac Risk Assessment Studies
Diagnostic & Invasive Cardiology:  Aug 26 2008 5:08PM Matching: cardiac science
The role of vitamin D for obese patients in reversing the type 2 diabetes pandemic
Endocrine Today:  Aug 25 2008 2:34PM Matching: cardiac science
Novel Method To Grow Human Embryonic Stem Cells Developed
Science Daily:  Aug 21 2008 7:59PM Matching: cardiac science
New method of growing human embryonic stem cells may revolutionise Parkinson's therapy
Webindia123:  Aug 20 2008 1:45PM Matching: cardiac science
Promote your company here: BioNewsCast - Press Release Distribution

View more Cardiac Science Corporation news.

Cardiac Science Corporation Patents:

US Patent No.Title
7174204 Methods for quantifying the morphology and amplitude of cardiac action potential alternans
6546285 Long term wear electrode for defibrillation system
6539255 Full-tilt exponential defibrillation waveform
6490478 System and method for complexity analysis-based cardiac tachyarrhythmia detection
6480734 Cardiac arrhythmia detector using ECG waveform-factor and its irregularity

View more Cardiac Science Corporation patents.

Cardiac Science Corporation (CSCX) Financial information Links from Barchart

CSCX Quote from from Barchart.com
CSCX Chart from from Barchart.com
CSCX Profile from from Barchart.com
CSCX Opinion from from Barchart.com

View more Cardiac Science Corporation finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 152 times since April 2007, the link to the organisation's website has been followed 25 times

Recent Search Terms used to find this page: N-cyanosulphonamide | Cardiac Science canada | S0859 patent | S0859 patent | .

Search for more companies in Bothell

Search for more companies in Washington



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Cardiac Science Corporation
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.